Risk Factors for Death Among 120,804 Hospitalized Patients with Confirmed COVID-19 in São Paulo, Brazil
Authors:
- Patricia Vieira da SilvaPSPatricia Vieira da Silva
- Silvano Barbosa de OliveiraSOSilvano Barbosa de Oliveira
- Juan José Cortez EscalanteJEJuan José Cortez Escalante
- Maria AlmironMAMaria Almiron
- Daniel Henrique TsuhaDTDaniel Henrique Tsuha
- Helena Keico SatoHSHelena Keico Sato
- Paulo Rossi MenezesPMPaulo Rossi Menezes
- Regiane Cardoso de PaulaRPRegiane Cardoso de Paula
- Tatiana Lang D’agostiniTDTatiana Lang D’agostini
- Julio CrodaJCJulio Croda
Open Access
- 31 May 2021
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. -1 (aop) , 88-92
Abstract
São Paulo is a state in Brazil with one of the highest numbers of confirmed and severe cases of coronavirus disease (COVID-19), with an incidence of 294 hospitalizations per 100,000 inhabitants. We report the clinical characteristics and outcomes of 120,804 hospitalized patients with confirmed COVID-19 from February 26 to October 10, 2020, in São Paulo. Characteristics of patients who died and survived were compared using a survival analysis. The median age was 60 years (interquartile range [IQR], 47–72), 67,821 (56.1%) were men, and 61,659 (51.0%) were white. Most hospitalized patients (79,812; 66.1%) reported one or more comorbidities, 41,708 (34.5%) hospitalized patients were admitted to intensive care units, and 33,079 (27.4%) died. Men (hazard ratio [HR], 1.22; 95% confidence interval [CI], 1.18–1.25), elderly individuals (HR, 3.85; 95% CI, 3.68–4.02), and patients with chronic cardiovascular disease including hypertension (HR, 1.05; 95% CI, 1.02–1.08), chronic lung disease (HR, 1.38; 95% CI, 1.31–1.45), diabetes mellitus (HR, 1.14; 95% CI, 1.11–1.18), and chronic neurological disease (HR, 1.48; 95% CI, 1.41–1.55) were at higher risk for death from COVID-19.Keywords
This publication has 8 references indexed in Scilit:
- Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysiseClinicalMedicine, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Routes for COVID-19 importation in BrazilJournal of Travel Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].2020
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe Lancet, 2020